MoonLake Immunotherapeutics (MLTX) vs MannKind Corporation (MNKD)
MoonLake Immunotherapeutics and MannKind Corporation are both Biotechnology companies. MoonLake Immunotherapeutics and MannKind Corporation are of similar size ($1.1B and $1.0B). MoonLake Immunotherapeutics has the higher net margin (0.00% vs −11.1%) and the lower return on invested capital (0.00% vs 2.36%). Across the 13 metrics below, MannKind Corporation leads on 9 and MoonLake Immunotherapeutics on 4.
Valuation
Profitability
| Metric | MLTX | MNKD | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 75.39% | 65.16% |
| Operating margin | 0.00% | 2.34% | 0.00% |
| Net margin | 0.00% | (11.08%) | 0.00% |
| Free cash flow margin | 0.00% | (4.61%) | 0.00% |
| Return on equity | (67.08%) | 71.36% | (57.72%) |
| Return on assets | (51.00%) | (7.62%) | (49.22%) |
| Return on invested capital | 0.00% | 2.36% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack